Yuhao Dong | Immunology and Microbiology | Best Scholar Award

Published on by Innovation Technologist

Best Scholar Award

Yuhao Dong
Nanjing Agricultural University, China

                    Yuhao Dong
Affiliation Nanjing Agricultural University
Country China
Scopus ID 56707567500
Documents 41
Citations 796
h-index 14
Subject Area Immunology and Microbiology
Event Global Innovation Technologist Awards

Yuhao Dong is a researcher affiliated with Nanjing Agricultural University, China, whose listed scholarly output includes studies on bacterial virulence, antimicrobial resistance, and microbial systems. His two supplied publications address CRISPR-dependent gene regulation in piscine Streptococcus agalactiae and the TonB system associated with macrolide resistance in Aeromonas hydrophila. These studies provide a basis for describing his research interests in microbial pathogenesis and bacterial resistance mechanisms. The bibliometric figures presented here are supplied profile data and should be checked against the current Scopus record before publication. [1] [2]

Abstract

This article presents a research profile of Yuhao Dong in relation to the Best Scholar Award. The supplied record lists 41 documents, 796 citations, and an h-index of 14. His two identified publications investigate bacterial gene regulation, virulence, and antimicrobial resistance. These topics are relevant to microbiology and infectious disease research. The profile summarizes the available information without treating bibliometric indicators alone as proof of research quality or independently verified award selection.

Keywords

Yuhao Dong; Best Scholar Award; microbiology; bacterial virulence; CRISPR-dependent gene regulation; antimicrobial resistance; Streptococcus agalactiae; Aeromonas hydrophila; research impact.

Introduction

Understanding bacterial pathogenesis and resistance is important for infectious disease research, animal health, and the study of microbial adaptation. Investigations into gene-regulatory systems can help clarify how bacteria maintain virulence, while research on efflux pumps and associated transport systems can inform the study of antimicrobial resistance. Dong’s supplied publications address these complementary questions through studies of bacterial species relevant to piscine and veterinary microbiology. [1] [2]

Research Profile

The supplied profile associates Dong with Nanjing Agricultural University in China and identifies Immunology and Microbiology as the subject area. His listed bibliometric indicators—41 documents, 796 citations, and an h-index of 14—offer quantitative measures of recorded publication and citation activity. Their interpretation depends on database coverage, profile accuracy, publication dates, and citation practices within the relevant discipline. [3]

Research Contributions

The 2021 study on piscine Streptococcus agalactiae examines CRISPR-dependent endogenous gene regulation in relation to bacterial virulence. The second study investigates the TonB system in Aeromonas hydrophila NJ-35 and its role in MacA2B2 efflux pump-mediated macrolide resistance. Together, these publications indicate research engagement with molecular mechanisms underlying bacterial pathogenicity and drug resistance. Specific experimental findings should be interpreted in the context of each full paper. [1] [2]

Publications

  1. Dong, Y. et al. (2021). “CRISPR-dependent endogenous gene regulation is required for virulence in piscine Streptococcus agalactiae.” Emerging Microbes & Infections, 10(1), 2113–2124. [1]
  2. Dong, Y. et al. (2021). “The TonB system in Aeromonas hydrophila NJ-35 is essential for MacA2B2 efflux pump-mediated macrolide resistance.” Veterinary Research, 52(1), article 63. [2]

These entries are based on the bibliographic details supplied for this article. DOI identifiers have not been independently established here and are therefore not inferred.

Research Impact

The supplied citation count and h-index suggest that Dong’s publications have received measurable scholarly attention. Citation indicators, however, vary with time and database coverage and do not independently establish the originality, reproducibility, or practical significance of individual findings. A fuller assessment would consider publication quality, methodological rigor, research contributions, collaboration, and the influence of the work on subsequent studies.

Award Suitability

The Best Scholar Award profile can present Dong’s documented research topics, publication record, and bibliometric indicators as information relevant to scholarly recognition. A fair assessment by the Global Innovation Technologist Awards should additionally verify the researcher’s identity, institutional affiliation, publication records, and eligibility against the award’s published criteria. This profile does not assert that an award has been formally granted.

Conclusion

Yuhao Dong’s supplied publication record highlights research into bacterial virulence and antimicrobial resistance. His reported bibliometric indicators provide context for reviewing his scholarly activity, while the two identified papers offer specific examples of his research interests. Verification of the underlying records and assessment of the scientific contributions remain important steps in preparing a complete award profile.

References

    1. Dong, Y. et al. (2021). “CRISPR-dependent endogenous gene regulation is required for virulence in piscine Streptococcus agalactiae.” Emerging Microbes & Infections, 10(1), 2113–2124. Bibliographic details supplied for this profile.
    2. Dong, Y. et al. (2021). “The TonB system in Aeromonas hydrophila NJ-35 is essential for MacA2B2 efflux pump-mediated macrolide resistance.” Veterinary Research, 52(1), article 63. Bibliographic details supplied for this profile.
    3. Elsevier. (n.d.). Scopus author details: Yuhao Dong, Author ID 56707567500. Scopus. Bibliometric figures in this article are based on the supplied profile data and should be confirmed against the current record.
      https://www.scopus.com/authid/detail.uri?authorId=56707567500
    4. Global Innovation Technologist Awards. (n.d.). Official award website. Award information and eligibility criteria should be verified on the official website.
      innovationtechnologist.com

Maria D. Chermá | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Maria D. Chermá
Linköping University, Sweden

Maria D. Chermá
Affiliation Linköping University
Country Sweden
Scopus ID 6507872208
Documents 13
Citations 181
h-index 8
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0003-0209-9967

Maria D. Chermá is a researcher associated with the Swedish academic and forensic science research environment. Her publication record reflects contributions to forensic toxicology, analytical chemistry, pharmacokinetics and the investigation of drug metabolism. Her research addresses scientific questions relevant to the detection, interpretation and evaluation of substances in biological specimens. Her documented publications and bibliometric indicators provide the foundation for recognition under the Best Researcher Award category.

Abstract

This academic recognition profile presents Maria D. Chermá’s research activities in medicine and health sciences, with particular emphasis on forensic toxicology and pharmacokinetic investigations. Her scholarly work includes studies examining anabolic androgenic steroids, zopiclone and oxycodone. These subjects demonstrate the relevance of analytical measurement and drug metabolism research to forensic interpretation and public health. The profile considers publication contributions, research visibility and documented academic indicators in relation to the Best Researcher Award.

Keywords

Forensic toxicology; pharmacokinetics; analytical chemistry; drug metabolism; mass spectrometry; substance use; medicine and health sciences; biological specimens; toxicological analysis.

Introduction

Forensic toxicology contributes to healthcare, criminal investigations and scientific understanding of substance exposure. Reliable identification and interpretation of drugs and their metabolites require validated analytical approaches and knowledge of pharmacokinetic processes. Chermá’s identified publications address these interconnected areas through investigations involving biological samples and drug-related measurements. Her work illustrates the importance of combining laboratory research with scientifically supported interpretation of toxicological findings.[3][4]

Research Profile

Her research profile is associated with analytical and forensic investigations of pharmaceutical and other substances. The supplied bibliometric information records 13 documents, 181 citations and an h-index of 8. These indicators offer quantitative perspectives on publication activity and citation visibility. They should be interpreted alongside research quality, methodological relevance, individual contributions and the scientific significance of published findings. Her ORCID identifier provides an additional means of distinguishing her scholarly record.[1][2]

Research Contributions

The identified research themes include:

  • Investigation of anabolic androgenic steroid use within a Swedish forensic population.
  • Pharmacokinetic evaluation of zopiclone and metabolite-to-parent ratios for estimating intake timing.
  • Examination of oxycodone pharmacokinetics and its phase I and phase II metabolites using LC–MS-MS.

Together, these topics demonstrate the importance of analytical toxicology in understanding substance exposure, metabolism and evidence interpretation.[3][4][5]

Publications

Three identified publications illustrate the breadth and continuity of her research interests:

  1. Use of anabolic androgenic steroids in a Swedish forensic population: Associations with substance use and criminal convictions. Drug and Alcohol Dependence, October 2026.
  2. Blood pharmacokinetics and use of metabolite-to-parent ratios to predict time of last zopiclone intake. Journal of Analytical Toxicology, 2026.[4]
  3. Urinary Pharmacokinetics of Immediate and Controlled Release Oxycodone and its Phase I and II Metabolites Using LC–MS-MS. Journal of Analytical Toxicology, 2022.[5]

Research Impact

The reported 181 citations and h-index of 8 indicate measurable scholarly visibility. The publication topics also connect laboratory-based research with practical forensic applications, particularly drug identification, exposure assessment and interpretation of biological measurements. Such contributions are relevant to the continuing development of analytical methods and evidence-based toxicological practice. Citation indicators provide useful context but do not independently establish research quality or societal impact.

Award Suitability

Maria D. Chermá’s documented research themes, publication activity and reported citation indicators provide relevant considerations for the Best Researcher Award under the Medicine and Health Sciences category. Her work addresses scientifically important questions in forensic toxicology and pharmacokinetics. The Global Innovation Technologist Awards recognize research contributions, scholarly development and the advancement of knowledge across disciplines. Final award assessment should consider verified authorship, individual research responsibilities and the applicable evaluation criteria.

Conclusion

Maria D. Chermá’s academic profile reflects research engagement in forensic toxicology, analytical chemistry and pharmacokinetic science. Her identified publications address drug metabolism and toxicological investigations with relevance to medicine and forensic applications. The reported bibliometric indicators and documented research themes establish a foundation for consideration in the Best Researcher Award category of the Global Innovation Technologist Awards. Her profile represents the contribution of analytical research to scientific understanding and evidence-based practice.

References

  1. Elsevier. (n.d.). Scopus author details: Maria D. Chermá, Author ID 6507872208. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6507872208
  2. ORCID. (n.d.). Maria D. Chermá: ORCID researcher identifier.
    https://orcid.org/0000-0003-0209-9967
  3. Chermá, M. D., et al. (2026). Use of anabolic androgenic steroids in a Swedish forensic population: Associations with substance use and criminal convictions. Drug and Alcohol Dependence.
    https://doi.org/10.1016/j.drugalcdep.2026.113410
  4. Gomonit, M. M., Nilsson, G. H., Nyström, I., Berglund, L., Kugelberg, F. C., Chermá, M. D., et al. (2026). Blood pharmacokinetics and use of metabolite-to-parent ratios to predict time of last zopiclone intake. Journal of Analytical Toxicology, 50(6).
    https://doi.org/10.1093/jat/bkag032
  5. Truver, M. T., Jakobsson, G., Chermá, M. D., Swortwood, M. J., Gréen, H., & Kronstrand, R. (2022). Urinary Pharmacokinetics of Immediate and Controlled Release Oxycodone and its Phase I and II Metabolites Using LC–MS-MS. Journal of Analytical Toxicology, 46(9), 1025–1031.
    https://doi.org/10.1093/jat/bkab123
  6. National Library of Medicine. (2026). Blood pharmacokinetics and use of metabolite-to-parent ratios to predict time of last zopiclone intake.

Jun Hu | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Jun Hu
The First Affiliated Hospital of Shantou University Medical College, China

Jun Hu
Affiliation The First Affiliated Hospital of Shantou University Medical College
Country China
Scopus ID 55712134300
Documents 39
Citations 651
h-index 15
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-1864-4862

Jun Hu is a medical researcher affiliated with The First Affiliated Hospital of Shantou University Medical College, China. His reported scholarly record includes 39 documents, 651 citations and an h-index of 15. These bibliometric indicators provide a quantitative overview of publication activity and citation visibility. His documented publications address clinical questions involving knee osteoarthritis, disparities in treatment outcomes and serious bacterial infections. The Best Researcher Award profile highlights these research contributions within the Medicine and Health Sciences subject area.

Abstract

This academic recognition profile summarizes Jun Hu’s reported research metrics and two 2026 journal articles concerning musculoskeletal health disparities and severe infectious disease. The publications illustrate distinct clinical research themes, including differences in pain and arthroplasty outcomes across racial groups and case-based reporting of group A β-hemolytic streptococcal infection associated with purpura fulminans. Bibliometric figures are presented as supplied and should be checked against the current Scopus author record. [1] [2]

Keywords

Jun Hu; Best Researcher Award; clinical research; medicine; health sciences; knee osteoarthritis; total knee arthroplasty; racial disparities; group A β-hemolytic streptococcus; purpura fulminans; bibliometrics.

Introduction

Medical research contributes to evidence-based practice by examining disease patterns, clinical outcomes and challenges affecting patient care. Research on osteoarthritis can help clarify variation in pain and access to joint replacement, while infectious disease case reports can document serious presentations that warrant clinical attention. Hu’s supplied publication records represent these complementary areas of investigation. The available information supports a focused account of the named studies but does not establish their individual methods or findings beyond the bibliographic details provided. [2] [3]

Research Profile

Hu’s reported scholarly profile comprises 39 documents, 651 citations and an h-index of 15. Together, these indicators describe publication volume, citation activity and a balance of productivity and citation reach. They should be interpreted alongside research quality, authorship contributions, methodological rigor and clinical relevance rather than as standalone measures of merit. His listed affiliation provides institutional context for the recognition profile. The supplied records do not establish a comprehensive account of his research appointments, specialist training or leadership responsibilities.

Research Contributions

The two supplied publications identify different clinical questions. The osteoarthritis article explicitly addresses racial disparities in pain and total knee arthroplasty across disease phenotypes. The infectious disease article reports two cases involving group A β-hemolytic streptococcus and purpura fulminans. Considered together, these topics concern both variation in musculoskeletal care and the documentation of severe infection. Their precise implications require interpretation of the full articles, including study design, results, limitations and clinical context. [2] [3]

Publications

  1. “Racial disparities in pain and total knee arthroplasty across knee osteoarthritis phenotypes.” Frontiers in Aging, published 20 May 2026. [2]
  2. “Group A β-hemolytic streptococcus causing purpura fulminans: two case reports.” Frontiers in Immunology, published 10 February 2026. [3]

Research Impact

The reported citation count and h-index indicate measurable scholarly visibility, although citation totals vary over time and across databases. The listed articles address subjects relevant to clinical research and patient care. A robust assessment of impact would additionally examine citation context, independent uptake, methodological quality, reproducibility and evidence of influence on clinical practice. No specific patient outcomes or changes to medical guidelines can be inferred from the bibliographic information alone. [1]

Award Suitability

The supplied publication record and bibliometric indicators provide relevant material for consideration under the Best Researcher Award at the Global Innovation Technologist Awards. A balanced evaluation should consider originality, the nominee’s verified contribution to each publication, research integrity, clinical relevance and independent evidence of impact. This profile summarizes submitted information and does not itself constitute independent verification or confirmation of an award decision.

Conclusion

Jun Hu’s reported research profile combines established bibliometric indicators with publications addressing osteoarthritis-related disparities and severe bacterial infection. These records provide a basis for reviewing his scholarly activity in medicine and health sciences. Verification of author identity, publication attribution and current citation data remains important for a complete and transparent recognition assessment.

References

  1. Elsevier. (n.d.). Scopus author details: Jun Hu, Author ID 55712134300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55712134300
  2. Frontiers. (2026). Racial disparities in pain and total knee arthroplasty across knee osteoarthritis phenotypes. Frontiers in Aging. DOI: 10.3389/fragi.2026.1819274.
    https://doi.org/10.3389/fragi.2026.1819274
  3. Frontiers. (2026). Group A β-hemolytic streptococcus causing purpura fulminans: two case reports. Frontiers in Immunology. DOI: 10.3389/fimmu.2026.1659910.
    https://doi.org/10.3389/fimmu.2026.1659910
  4. ORCID. (n.d.). Jun Hu: ORCID researcher identifier.
    https://orcid.org/0000-0002-1864-4862
  5. Global Innovation Technologist Awards. (n.d.). Official award website.
    innovationtechnologist.com

Mercedes Cao Vilariño | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Research Excellence Award

Mercedes Cao Vilariño
Universitary Hospital, Spain

Mercedes Cao Vilariño
Affiliation Universitary Hospital
Country Spain
Scopus ID 57195055799
Documents 5
Citations 15
h-index 3
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards

Mercedes Cao Vilariño is a researcher associated with medical and health sciences in Spain. Her documented research includes a 2020 publication examining smoking cessation support and carbon monoxide monitoring among kidney transplant patients who smoke. This article presents a research profile and recognition overview for the Research Excellence Award associated with the Global Innovation Technologist Awards. The available bibliographic information and supplied research metrics provide the basis for this summary; further verification is needed to establish a comprehensive publication record and award decision.

Abstract

This profile summarizes the supplied academic indicators and a reported clinical research publication associated with Mercedes Cao Vilariño. The study concerns a randomized clinical trial investigating carbon monoxide monitoring using CO-oximetry and brief anti-smoking advice for kidney transplant recipients who smoke. The topic connects preventive healthcare, tobacco cessation, and the management of health risks in transplant populations. Supplied bibliometric figures list five documents, 15 citations, and an h-index of three; these values should be interpreted according to the source and date of retrieval. [1] [2]

Keywords

Mercedes Cao Vilariño; medicine and health sciences; kidney transplantation; smoking cessation; CO-oximetry; clinical research; preventive medicine; research impact; research excellence.

Introduction

Research excellence in healthcare involves the systematic investigation of clinical questions, evaluation of evidence, and potential translation of findings into practice. Smoking cessation is particularly relevant to patients with complex medical histories, including kidney transplant recipients. Research into brief interventions and objective monitoring methods may inform approaches to identifying tobacco use and supporting cessation. The listed publication provides a specific bibliographic point of reference for understanding this research area. [1]

Research Profile

The supplied profile associates the researcher with a hospital institution in Spain and the subject area of medicine and health sciences. The Scopus author identifier provides a route to reviewing indexed publications and associated citation records. Affiliation details, author-name variants, and profile metrics may change over time; institutional and database records should therefore be consulted for current verification. [2]

Research Contributions

The identified clinical trial addresses two components of smoking-related care: carbon monoxide assessment and brief anti-smoking advice. Its focus on kidney transplant recipients places the investigation within a specialized clinical population. The study title indicates a randomized trial design, although detailed conclusions, sample characteristics, and outcome estimates should be drawn from the full publication rather than inferred from bibliographic metadata alone. [1]

Publications

The supplied record identifies the following publication:

  • “Randomized clinical trial to determine the effectiveness of CO-oximetry and anti-smoking brief advice in a cohort of kidney transplant patients who smoke.” International Journal of Medical Sciences, 2020. The supplied record lists Mercedes Cao Vilariño among the authors. [1]

Research Impact

The supplied indicators report five documents, 15 citations, and an h-index of three. Citation counts offer one measure of scholarly visibility, but they do not independently establish research quality, clinical effectiveness, or societal benefit. A fuller assessment would consider study design, methodological rigor, reproducibility, collaboration, and relevance to patient care. These indicators should be checked against the current Scopus record before formal publication. [2]

Award Suitability

The Research Excellence Award profile highlights a documented contribution to clinical research relevant to tobacco cessation and transplant care. Consideration for recognition may include verified publications, methodological contributions, independent evidence of impact, and the candidate’s wider research record. This profile describes award-related recognition context and does not, by itself, confirm that an award has been formally conferred.

Conclusion

Mercedes Cao Vilariño’s supplied research profile includes a clinical publication on smoking-related intervention in kidney transplant patients. The reported bibliometric indicators offer a concise snapshot of scholarly activity, while a complete evaluation requires examination of the publication, current author records, and broader evidence of research contribution. Accurate attribution and transparent verification remain essential to responsible academic recognition.

References

  1. Seijo-Bestilleiro, R., Seoane-Pillado, M. T., Pértega-Díaz, S. D., Cao Vilariño, M., Gil-Guillén, V. F., et al. (2020). Randomized clinical trial to determine the effectiveness of CO-oximetry and anti-smoking brief advice in a cohort of kidney transplant patients who smoke.
  2. Elsevier. (n.d.). Scopus author details: Mercedes Cao Vilariño, Author ID 57195055799. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57195055799
  3. International Journal of Medical Sciences. (2020). Journal publication record for the randomized clinical trial on CO-oximetry and smoking cessation advice in kidney transplant patients.
  4. Global Innovation Technologist Awards. (n.d.). Official awards website.
    innovationtechnologist.com/

Fan Zhou | Immunology and Microbiology | Research Excellence Award

Published on by Innovation Technologist

Dr. Fan Zhou | Immunology and Microbiology | Research Excellence Award

Associate Chief Physician | Nanjing Drum Tower Hospital | China

Dr. Fan Zhou is a clinician-scientist specializing in inflammatory bowel disease and gastric cancer, with a strong focus on the immune microenvironment and tumor immune escape mechanisms. His research integrates molecular immunology with translational medicine to identify pathways that drive cancer progression and inflammation-related disease. He has authored multiple peer-reviewed publications in leading international journals across oncology and immunology. As a principal investigator and contributor to nationally and provincially funded projects, his work advances mechanistic understanding and supports the development of personalized therapeutic strategies with clear clinical relevance.

Citation Metrics (Orcid)

10

8

6

4

2

0

Citations
9

Document 1

Citations

Document


View ORCID Profile

Meysam Moravedji | Zoonoses | Outstanding Scientist Award

Published on by Innovation Technologist

Dr. Meysam Moravedji | Zoonoses | Outstanding Scientist Award

Veterinarian Researcher at Islamic Azad University, Sanandaj Branch, Sanandaj, Iran

Dr. Meysam Moravedji is an experienced veterinary internist specializing in large animal medicine, with a particular focus on equine and ruminant health. He serves as an Assistant Professor at the Faculty of Veterinary Medicine, Islamic Azad University, Sanandaj Branch, Iran. With over 15 years of academic, clinical, and research experience, he has made significant contributions to veterinary education, large animal clinical services, zoonotic disease research, and rural animal health outreach. He has actively collaborated with major scientific institutions such as the Pasteur Institute of Iran and the Razi Vaccine and Serum Research Institute.

Publication Profile 

Scopus

Google Scholar

Educational Background 🎓

  • DVSc in Large Animal Internal Medicine
    Shahid Chamran University of Ahvaz, Iran – 2013

  • DVM (Doctor of Veterinary Medicine)
    Islamic Azad University, Karaj Branch, Iran – 2007

Professional Experience 💼

  • Assistant Professor, Dept. of Clinical Sciences, Faculty of Veterinary Medicine, Islamic Azad University, Sanandaj Branch (2010–Present)

  • Head, Large Animal Clinic (2023–2024)

  • Director, Mobile Veterinary Clinic (2021–Present)

  • Veterinary Health Officer, Faculty Farms (2017–2018)

  • Member, Faculty Research Council (2017–2018, 2020–2021)

  • University Graduate Studies Representative (2017–2018)

  • Permanent Member, Specialized Council, Clinical Sciences Department (2010–Present)

  • Lecturer, Continuing Education Programs for Veterinary Councils in multiple provinces

  • Owner and Part-time Veterinary Practitioner, Large Animal Clinic, Sanandaj (2020–Present)

  • Project Collaborator, Pasteur Institute of Iran and Razi Institute

Research Interests 🔬

  • Zoonotic Diseases and Public Health

  • Large Animal Internal Medicine

  • Equine Medicine: colic, cardiology, ophthalmology

  • Emerging and Re-emerging Infectious Diseases

  • Tick-Borne Diseases

  • Fluid Therapy in Large Animals

  • Animal Modeling for Equine Digestive Disorders

  • Veterinary Clinical Sciences and Biosecurity

Awards and Honors🏆✨

  • Head, Horse Medicine Panel, 4th Iranian Congress of Companion Animal Medicine (2025)

  • Organizer, Joint Scientific Meeting with Pasteur Institute and Razi Institute (2024)

  • Keynote Speaker, Iranian Congress of Companion Animal Medicine

  • Recognized for community service to rural and underprivileged farmers

Professional Services and Engagements

  • Peer Reviewer for:

    • BMC Veterinary Research

    • International Journal of Veterinary Science and Research

    • Iranian Journal of Veterinary Clinical Sciences

    • Journal of Large Animal Clinical Science Research

  • Symposium Organizer and Speaker:

    • Iranian Congress of Companion Animal Medicine

    • Scientific Meetings with national research institutes

  • Community Outreach:

    • Free veterinary care for farmers in Kurdistan Province

    • Educational workshops for rural livestock owners

    • Veterinary consulting for Eram Zoo (Tehran)

Conclusion🌟

Dr. Meysam Moravedji exemplifies an outstanding veterinary academic and practitioner with an exceptional record of clinical service, teaching, and research in large animal internal medicine. His extensive contributions to equine health, zoonotic disease research, and rural veterinary service have had meaningful impacts at institutional and community levels. He is a strong candidate for recognition in scientific and professional award platforms, particularly those honoring contributions in veterinary medicine, public health, and translational animal research. Future endeavors could include expanding his international research collaborations and further publications in high-impact veterinary journals.

Publications 📚

  • 📄 Molecular detection, epidemiology and phylogenetic evaluation of Babesia ovis in apparently healthy goats
    🧬 FI Asia Taqddus, Muhammad Naeem, Hira Muqaddas, Ceylan Ceylan, Onur Ceylan, …
    🏛️ Research in Veterinary Science, 191, 105672.

  • 📄 Detection of Various Rickettsial Species in Ticks Collected from Small Ruminants in Western Iran
    🧪 M Moravedji, M Latifian, M Rahravani, E Mostafavi, H Seyfi, …
    🏛️ Vector-Borne and Zoonotic Diseases, 24(11), 730–737.

  • 📄 Determination of seroprevalence of brucellosis in livestock and high-risk population in Kurdistan, Western Iran
    🧫 S Aghamohammad, M Rastin, E Mostafavi, AH Anaraki, M Rahravani, …
    🏛️ Comparative Immunology, Microbiology and Infectious Diseases, 93, 101942.
    🔢 Cited by: 7

  • 📄 Clinical, hematological and molecular evaluation of piroplasma and Anaplasma infections in small ruminants and tick vectors from Kurdistan province, western Iran
    🐑 M Rahravani, M Moravedji, E Mostafavi, MM Mozoun, AH Zeeyaie, …
    🏛️ Research in Veterinary Science, 159, 44–56.
    🔢 Cited by: 4

  • 📄 Molecular detection of Brucella abortus and Brucella melitensis in domestic ruminants and their ticks in selected areas of western Iran
    🔬 M Moravedji, M Beig, N Baseri, M Rahravani, M Latifian, S Esmaeili
    🏛️ Iranian Journal of Veterinary Research, 24(3), 270.
    🔢 Cited by: 2

  • 📄 The epidemiological survey of Coxiella burnetii in small ruminants and their ticks in western Iran
    🐏 M Rahravani, M Moravedji, E Mostafavi, M Mohammadi, H Seyfi, N Baseri, …
    🏛️ BMC Veterinary Research, 18(1), 292.
    🔢 Cited by: 28

  • 📄 Molecular detection of Francisella tularensis in small ruminants and their ticks in western Iran
    🔬 M Rahravani, M Moravedji, E Mostafavi, N Baseri, H Seyfi, M Mohammadi, …
    🏛️ Comparative Immunology, Microbiology and Infectious Diseases, 83, 101779.
    🔢 Cited by: 13

  • 📄 Seroepidemiology of leptospirosis in livestock and workers of high-risk occupation in Kurdistan, Iran
    💉 S Aghamohammad, AH Anaraki, M Rahravani, M Rastin, RA Sadaf, …
    🏛️ Comparative Immunology, Microbiology and Infectious Diseases, 82, 101758.
    🔢 Cited by: 3

  • 📄 Francisella tularensis survey among ranchers and livestock in western Iran
    🐄 HA Cohan, M Jamshidian, M Rohani, M Moravedji, E Mostafavi
    🏛️ Comparative Immunology, Microbiology and Infectious Diseases, 74, 101598.
    🔢 Cited by: 6

  • 📄 Study the impairments in clinical and microscopic diagnosis of theileriosis among small ruminant population in Kurdistan province
    🧪 H Seifi, M Moravedji, S Esmaeili, E Mostafavi
    🏛️ Journal of Large Animal Clinical Science Research (JLACSR), 9(1), 53–66.

  • 📄 Surveillance of Francisella tularensis in surface water of Kurdistan province, west of Iran
    💧 HA Cohan, M Jamshidian, M Rohani, M Moravedji, E Mostafavi
    🏛️ Comparative Immunology, Microbiology and Infectious Diseases, 69, 101419.
    🔢 Cited by: 5

  • 📄 Investigation the Frequency of Pathological Lesions of Sheep Rumen in Sanandaj Slaughter
    🐑 M Moravedji, L Akradi, M Khezai
    🏛️ Journal of Veterinary Research

  • 📄 Investigation of the frequency of pathological lesions of sheep rumen in Sanandaj slaughter
    🧫 H Khanbabaie, M Moravedji, L Akradi, M Khezri

  • 📄 Survey of the Microscopic Prevalence of the Abomasal Ulcer Types in Slaughtered Sheep of Slaughter House of Sanandaj County
    🔍 S Fathi, M Moravedji, L Akradi
    🏛️ Journal of Large Animal Clinical Science Research (Journal of Veterinary …)

 

 

 

 

Dimosthenis Chochlakis | Microbiology | Best Researcher Award

Published on by Innovation Technologist

Dr. Dimosthenis Chochlakis | Microbiology | Best Researcher Award

Researcher Microbiology-epidemiology at School of Medicine/University of Crete, Greece

Dr. Dimosthenis Chochlakis is a seasoned molecular microbiologist and medical biochemist affiliated with the University of Crete’s School of Medicine. With over two decades of experience in research, diagnostics, and academic teaching, he has made significant contributions to the understanding and surveillance of vector-, water-, and food-borne pathogens. His work bridges clinical microbiology and public health, emphasizing interdisciplinary methods, molecular diagnostics, and applied research.

Publication Profile 

Scopus

Educational Background 🎓

  • PhD in Molecular Microbiology (2006–2009)
    University of Crete, School of Medicine, Greece

  • MSc in Clinical Biochemistry with Molecular Biology (2000–2001)
    University of Surrey, Guildford, UK

  • BSc in Medical Biochemistry (1997–2000)
    University of Surrey, Guildford, UK

Professional Experience 💼

  • 2015–Present: Biochemistry & Microbiology Researcher
    Laboratory of Clinical Bacteriology, Parasitology, Zoonoses and Geographical Medicine, University of Crete

  • 2009–2014: Biochemistry & Microbiology Specialist
    Regional Laboratory of Public Health of Crete, National School of Public Health, Greece

  • 2004–2009: Research Associate
    Laboratory of Clinical Bacteriology, Parasitology, Zoonoses and Geographical Medicine, University of Crete

  • Various Teaching Roles (2004–2023): Lecturer in Biochemistry, Pharmacology, Microbial Metabolism, Fermentation, Public Health, and Zoonoses at vocational institutes and universities, including the University of Crete

  • Supervision: Has supervised 10 undergraduate and postgraduate students on diverse microbiological research topics.

Research Interests 🔬

  • Molecular epidemiology and laboratory diagnosis of zoonoses, especially tick-, water-, and food-borne pathogens

  • Surveillance systems and public health interventions related to Legionella, Coxiella burnetii, Leptospira, Listeria, and Vibrio species

  • Application of molecular diagnostics, GIS-based epidemiological mapping, and proteomics

  • Development of environmental surveillance tools for cross-border infectious threats

  • Public health microbiology with a focus on climate-influenced pathogen transmission

Awards and Honors🏆✨

  • Certified Evaluator, General Secretariat of Research and Technology (Greece), since 2016

  • Numerous invitations to lecture in postgraduate programs and international courses

  • Active organizer and technical committee member in international scientific events, including EurNegVec and BEPR

  • Participated in international collaborations (e.g., Serbia Ministry of Education, EU Horizon projects)

Conclusion🌟

Dr. Dimosthenis Chochlakis stands out as a distinguished researcher with sustained contributions to public health microbiology and zoonotic disease control. His interdisciplinary expertise in molecular microbiology, diagnostics, teaching, and field-based epidemiology makes him a vital contributor to the European and Mediterranean infectious disease surveillance landscape. His proactive involvement in EU-funded projects and teaching initiatives demonstrates leadership, innovation, and an ongoing commitment to advancing scientific knowledge and public health interventions.

Publications 📚

  • 🧬 A customizable multiplex protein microarray for antibody testing and its application for tick-borne and other infectious diseases
    👨‍🔬 H.K. Krishnamurthy, V. Jayaraman, K. Krishna, … A.M. Escárcega Ávila, J.J. Rajasekaran
    📝 Scientific Reports | 📅 2025 | 📊 Citations: 0

  • 💧 Challenges on the implementation of wastewater-based epidemiology as a prediction tool: the paradigm of SARS-CoV-2
    👨‍🔬 D. Chochlakis, G. Tzedakis, A. Kokkinomagoula, … V. Sakkalis, A. Psaroulaki
    📝 Science of the Total Environment | 📅 2025 | 📊 Citations: 0

  • 🏖️ Recreational Water Safety in Hotels: Lessons from the COVID-19 Pandemic and the Way Forward for a Safe Aquatic Environment
    👨‍🔬 A. Papadakis, D. Chochlakis, E. Koufakis, V.J. Karagianni, A. Psaroulaki
    📝 Tourism and Hospitality | 📅 2024 | 📊 Citations: 1 | 🔓 Open Access

  • 🚿 Multi-criterion analysis of the effect of physico-chemical microbiological agents on Legionella detection in hotel water distribution systems in Crete
    👨‍🔬 D. Chochlakis, V. Sandalakis, A. Ntoukakis, … C. Panoulis, A. Psaroulaki
    📝 Frontiers in Cellular and Infection Microbiology | 📅 2023 | 📊 Citations: 0 | 🔓 Open Access

  • 🦠 Giant cell arteritis associated with acute Q fever – A case report
    👨‍🔬 E. Sarra, C.C. Mylonas, G.A. Tsekes, … A. Psaroulaki, Μ.C. Chini
    📝 Journal of Infection and Chemotherapy | 📅 2022 | 📊 Citations: 0

  • 🏊 Swimming Pool Regulations in the COVID-19 Era: Assessing Acceptability and Compliance in Greek Hotels in Two Consecutive Summer Touristic Periods
    👨‍🔬 K. Mellou, A. Mplougoura, G.D. Mandilara, … A. Psaroulaki, A.T. Mavridou
    📝 Water Switzerland | 📅 2022 | 📊 Citations: 4 | 🔓 Open Access

  • 🐑 Serological survey of Chlamydia abortus in Greek dairy sheep flocks
    👨‍🔬 E.I. Petridou, E.A. Kiossis, D. Chochlakis, … M. Baratelli, N.D. Giadinis
    📝 Journal of the Hellenic Veterinary Medical Society | 📅 2022 | 📊 Citations: 0 | 🔓 Open Access

Jatinder Kumar | Health Care Services | Best Researcher Award

Published on by Innovation Technologist

Dr. Jatinder Kumar | Health Care Services | Best Researcher Award

IT Professional at PGIMER, Chandigarh, India

Dynamic IT professional with over 25 years of experience in software development, network infrastructure, and IT solutions. Specializes in full-stack development, cloud computing (AWS, Azure), network security, and virtualization technologies. Experienced in integrating business strategy with technology to enhance IT operations. Holds extensive expertise in hospital information systems, data analytics, and artificial intelligence applications in healthcare.

Publication Profile 

Scopus

Educational Background 🎓

  • PhD in Computer Science, Chitkara University (2024)
  • Master of Philosophy (Computer Science), MMU, Sadopur, Ambala, Haryana (2013)
  • Master of Business Administration (MBA), Panjab University, Chandigarh (2006)
  • Master of Computer Applications (MCA), Panjab University, Chandigarh (1997)
  • Bachelor of Science (B.Sc.), M.A.M. College, Jammu (1994)

Professional Experience 💼

  • Software Engineer, Trident InfoTech Corporation Limited, Chandigarh
    • Developed software solutions and contributed to system design and deployment.
    • Worked on enterprise-level applications for various industries.
  • Computer Programmer, PGIMER, Chandigarh (Since 2001)
    • Key contributor to the implementation of the Hospital Information System (HIS) for a 2,500-bed hospital.
    • Designed and developed the inventory module using process flow diagrams and entity-relationship diagrams.
    • Enhanced patient care, reduced wait times, and streamlined administrative workflows.
    • Involved in system integration, cloud-based solutions, and data migration strategies.

Research Interests 🔬

  • Artificial intelligence and deep learning applications in healthcare.
  • Medical imaging and thyroid nodule analysis using deep learning models.
  • Multi-agent system frameworks for efficient hospital administration.
  • Cloud computing and security solutions for healthcare IT systems.
  • e-Governance and digital transformation in public healthcare.

Awards and Honors🏆✨

  • Best Paper Presentation, TELEMEDICON 2024, PGIMER, Chandigarh.
  • Best Paper Presentation, ICAAIML 2024, Hyderabad, India.
  • First Prize in Yoga Competition, International Yoga Day 2024, PGIMER, Chandigarh.
  • Represented Chandigarh in National Yoga Competitions in Telangana and Rajasthan.
  • Conducting yoga classes and educational support for underprivileged children in Chandigarh.
  • Various professional certifications in hardware, Oracle, and MCSE.

Conclusion🌟

With an extensive background in IT, healthcare systems, and artificial intelligence, the author has made significant contributions to hospital information systems and deep learning applications in medical imaging. His research and professional work have enhanced patient care and operational efficiency in healthcare institutions. Recognized for academic excellence and community service, he continues to drive innovation in AI-driven healthcare solutions and IT infrastructure development.

Publications 📚

📖 Kumar, J., Panda, S.N., & Dayal, D. (2023, December). Deep Learning for Improved Thyroid Nodule Analysis in Ultrasound Images. INTERNATIONAL JOURNAL OF RESEARCH AND ANALYTICAL REVIEWS (IJRAR.ORG), Volume 10, Issue 4.

📖 Kumar, J., Panda, S.N., & Dayal, D. (2023). Utilizing Deep Learning Models for the Classification of Thyroid Nodules in Ultrasound Images. The International Journal of Engineering and Science (IJES), Volume 12, Issue 11, Pages 18-31.

📖 Kumar, J., Panda, S.N., & Dayal, D. (2023, December). An Overview of Deep Learning Methods for Segmenting Thyroid Ultrasound Images. International Journal of Advanced Engineering and Nano Technology (IJAENT), ISSN: 2347-6389 (Online), Volume 10, Issue 12.

📖 Kumar, J., Panda, S.N., Dayal, D., & Sharma, M. (2024). Enhancing Thyroid Nodule Assessment with Deep Learning and Ultrasound Imaging. e-Prime – Advances in Electrical Engineering, Electronics, and Energy (Scopus). (Submitted after revision, awaiting acceptance letter.)

🎙️ Kumar, J., Panda, S.N., & Dayal, D. (2023, November). Deep learning routes to thyroid ultrasound image segmentation: A review. AIP Conference Proceedings, Vol. 2878, No. 1. AIP Publishing.

🎙️ Kumar, J., Panda, S.N., Dayal, D., & Sharma, M. (2023, September). Review of Deep Learning Techniques Over Thyroid Ultrasound Image Segmentation. 2023 International Conference on Sustainable Emerging Innovations in Engineering and Technology (ICSEIET), pp. 320-326. IEEE.

🎙️ Kumar, J., Panda, S.N., & Dayal, D. (2023). Pediatric Thyroid Ultrasound Image Classification Using Deep Learning: A Review. Chitkara University Doctoral Consortium – CUDC 2023.

🎙️ Kumar, J., Panda, S.N., & Dayal, D. (2024). Improving Thyroid Nodule Evaluation Using Deep Learning and Ultrasound Imaging. National Telemedicine Conference – TELEMEDICON 2024, held in Chandigarh (November 28-30, 2024).